The original success of Viagra undeniably reshaped the pharmaceutical landscape, but betting in companies heavily reliant on off-patent versions presents a challenging picture. Although early earnings were significant, the expiration of patents and the emergence of less expensive alternatives have eroded sales. Consequently, a thorough analysis of